5 técnicas simples para Inspire therapy

5 técnicas simples para Inspire therapy

Blog Article

If you are undergoing CPAP therapy and regularly wake up to pain on both sides of your head, you may be experiencing a CPAP headache.

Continuous positive airway pressure (CPAP) therapy is the most common treatment used across the spectrum of obstructive sleep apnea (OSA) severity, and is the recommended initial treatment for most patients with moderate to severe OSA.

Clinical studies have demonstrated that Inspire sleep apnea treatment is safe, though all surgeries carry risks. Incidents of serious complications related to the surgical procedure were less than 2%. In rare cases, extreme discomfort may require another operation to reposition the device.

"Most people do not end up with the first device they try. Some people may try two or three before finding the right fit," he says.

Through a simple-to-use system including the Inspire implant, remote and app, Inspire therapy enables you to control your therapy from the palm of your hand.

Try a Mask Liner: Mask liners can help you maintain a stronger seal throughout the night. Some mask liners are designed to soak up facial oils and sweat so that your mask cushion does not shift as you sleep.

In patients with minimally symptomatic OSA can baseline characteristics and early patterns of CPAP usage predict those who are likely to be longer-term users of CPAP.

"I was a side sleeper, and the pillow would knock the mask out of place," Levey says. So instead of sleeping through the night, he’d wake up repeatedly with air from the device blowing into his eyes.

Only a subset of sleep apnea patients are eligible for Inspire sleep apnea treatment. It’s only available with a doctor’s prescription, and there are a variety more info of eligibility requirements.

Summary: When patients with OSA are unwilling or unable to tolerate CPAP therapy, the following options should be considered:

CPAP may help oxygenation by methods of lung recruitment or keeping airways open but it does not aid in the clearance of CO2 and is not considered a method of non-invasive ventilation (NIV).

At this juncture, should the patient still not tolerate CPAP, then a surgical consultation is indicated. A thorough clinical history and examination is warranted to elicit potential therapeutic targets. A full assessment of co-morbidities and specifically body mass index is required, as the latter has been shown to correlate with surgical outcomes.

1 "We believe this unprecedented decision by the FDA will generate broader acceptance throughout the medical community for Vivos treatment options, leading to the potential for higher patient referrals and case starts as well as collaboration with medical professionals.”

The latest clearance comes less than a year after the FDA granted Vivos 510(k) clearance for the DNA oral appliance to treat mild to moderate OSA.